OSSIO, a fast-growing medical device company focused on evolving orthopedic surgery with bio-integrative fixation technology, closed on $27.6 million in equity funding. Questa Capital, which focuses on investments in expansion-stage healthcare companies, led this latest round of financing with participation from existing investors: MVM Partners, OCV, Ortho-Vision and Courage Capital.

This round will help rapidly scale all aspects of its commercial efforts, including a new product pipeline, sales channel and medical education, as well as building out a flagship U.S. manufacturing site and surgeon training center in Florida.